Acellular Pertussis Completed Phase 3 Trials for Poliovirus type 2 antigen (formaldehyde inactivated) (DB10796)

IndicationStatusPhase
DBCOND0031302 (Acellular Pertussis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02096263Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy InfantsPrevention
NCT00290342Evaluation of the Immunogenicity, Safety and Reactogenicity of the Combined DTPa-IPV Vaccine in Healthy InfantsPrevention
NCT00871117Immunogenicity and Safety of Kinrix + (Measles Mumps Rubella) MMR Vaccine With and Without Varicella Vaccine in Healthy Children 4-6 YearsPrevention
NCT00879827Immunogenicity and Reactogenicity of GSK Bio DTPa-HBV-IPV and Hib Vaccines When Coadministered to Healthy InfantsPrevention